Program Leaders: Mary Ann Osley, PhD, and Steven Belinsky, PhD
The Cancer Genetics, Epigenetics, and Genomics Research Program (CGEG) is a trans-disciplinary program that
The research of the Program encompasses three specific aims centered on:
The Program is co-led by Steven Belinsky, PhD, an expert in the application of translational epigenomics to lung cancer etiology, and Mary Ann Osley, PhD, an expert in the definition of basic epigenetic mechanisms in genome regulation.
The program is comprised of 27 members (22 full and 5 associate) from 14 Departments/Schools/Consortium Partners whose work is supported by $6,736,043 in annual direct cost funding, of which $2,005,422 is from the NCI and $6,252,544 is peer-reviewed as of 9/1/2014. The discoveries made in this program have resulted in 226 publications, of which 32% are intra-programmatic collaborations and 31% are inter-programmatic collaborations, with a total collaborative publication level of 52%.